Datar Cancer Genetics has partnered with Kokilaben Dhirubhai Ambani Hospital, Mumbai, to bring their series of unique revolutionary blood tests for early and easy detection of cancer. The first-of-its-kind range of cancer screening tests includes EasyCheck360 and EasyCheck Femmesafe. The EasyCheck cancer tests will help in the early detection of cancer that is critical for successful treatment and cure. These easy blood tests overcome the challenges of conventional cancer screening procedures that are invasive and resource-intensive.

“Cancer has become a chronic disease and one which can be treated successfully if detected early. The key to beating cancer is screening and early detection.  Early detection will lead to a high chance of survival in most cases. EasyCheck360 is a breakthrough test and will go a long way in helping witness a cancer-free India,” said Samara Mahindra, Director, New Cancer Initiatives, Datar Cancer Genetics.

“Cancer is one of the leading causes of death from non-communicable diseases. While early detection helps in increasing the chances of a faster recovery, studies have shown that the majority of cancers were diagnosed at an advanced stage. Only a low proportion presents in the early stages. Creating awareness about the need for early detection of cancer and the availability of easy, simple tests for the same would help in catching cancer early. We are glad to offer the EasyCheck range of cancer tests that will go a long way in battling the dreaded disease of cancer,” said Dr. Santosh Shetty, Executive Director and CEO, Kokilaben Dhirubhai Ambani Hospital

The EasyCheck360, EasyCheck Femmesafe and EasyCheck Prostrate are early cancer screening tests that detect the existence of cancer. The EasyCheck360 is not a genetic predisposition test and is a real-time test. The test also indicates the location for the select types of cancers with high accuracy, and in others, the Tissue of Origin can be identified. A 'positive' result is interpreted by the oncologist for a further course of action. The early detection will result in a higher chance of recovery and survival, minimal treatment cost and better quality of life.